Background illustration for clinical trials search

Paid Clinical Trials Ohio

Discover 3,089 paid clinical trials in Ohio. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication

for
Tobacco-Related Carcinoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 21+

Code: NCT07346092

Recruiting

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

for
Depressive Disorder, Major
Location: Boston MA, East Providence RI, New Haven CT,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 12 - 17

Code: NCT07227454

Phase 3, Recruiting

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

for
Osteogenesis Imperfecta (OI)
Location: New Haven CT, Wilmington DE, Toronto, Columbus OH,
Sponsor: Angitia Incorporated Limited

Sex: All

Age: 18 - 70+

Code: NCT07062588

Phase 2, Recruiting

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

for
Glioblastoma, GBM
Location: Boston MA, Long Island City NY, New York NY, Albany NY,
Sponsor: Alpheus Medical, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225621

Phase 2, Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

for
AChR-Ab Seropositive Generalized Myasthenia Gravis,
Location: Boston MA, Durham NC, Chapel Hill NC, Miami FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07284420

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

for
Multiple Sclerosis (MS) Primary Progressive
Location: Livingston NJ, Raleigh NC, Orlando FL, Maitland FL,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07067463

Phase 3, Recruiting

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07215988

Recruiting

Youth Empowerment and Safety Intervention

for
Suicide, Self-Injurious Behavior
Location: Cleveland OH
Sponsor: Case Western Reserve University

Sex: All

Age: 12 - 17

Code: NCT07214233

Recruiting

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

for
Catecholaminergic Polymorphic Ventricular Tachycardia
Location: Boston MA, Cleveland OH, Rochester MN, Vancouver
Sponsor: Solid Biosciences Inc.

Sex: All

Age: 7+

Code: NCT07148089

Phase 1, Recruiting

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

for
Focal Seizures
Location: New Haven CT, Hawthorne NY, Edison NJ, New Brunswick NJ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT07233239

Phase 1, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Scarborough ME, Burlington MA, New Haven CT, Lebanon NH,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase 3, Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Hackensack NJ, Richmond VA, Pittsburgh PA, Atlanta GA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06980038

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Halifax, Foxborough MA, Wellesley MA, Worchester MA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase 3, Recruiting

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Charlottesville VA, Pittsburgh PA, Wesley Chapel FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07012031

Phase 1, Phase 2, Recruiting

Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting

for
Healthy
Location: Youngstown OH
Sponsor: Youngstown State University

Sex: All

Age: 18+

Code: NCT07258030

Recruiting

Spine Oncology Registry

for
Spine Tumor, Spine Metastases, Spine Cancer
Location: New Brunswick NJ, Baltimore MD, Columbus OH,
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07225491

Recruiting

An International Observational Study of Adults With Acute Infection

for
Infectious Disease
Location: New York NY, Durham NC, Winston-Salem NC, Morgantown WV,
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT07069400

Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

for
Recurrent Glioblastoma, Recurrent Gliomas
Location: New York NY, Columbus OH, Scottsdale AZ
Sponsor: Alpha Tau Medical LTD.

Sex: All

Age: 18 - 70+

Code: NCT06910306

Recruiting

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

for
Sickle Cell Disease
Location: New York NY, Greenville NC, Durham NC, Pittsburgh PA,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT07187973

Phase 1, Recruiting

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Hartford CT, New Haven CT, New York NY, Teaneck NJ,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05659381

Phase 3, Recruiting

Popular cities in Ohio

With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.

Why choose Ohio for clinical trials?

Ohio offers distinct advantages in the clinical research landscape. The state's diverse population provides a wide range of participants, enhancing the accuracy and relevance of research outcomes. Ohio is also recognized for its strong research environment, with a focus on medical innovation and pioneering studies in various fields.

By choosing to participate in a clinical trial in Ohio, participants contribute to vital medical research while benefiting from a well-established clinical trial infrastructure supported by top-tier healthcare institutions. This ensures they receive cutting-edge care and support throughout the process.

Common conditions studied in Ohio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Ohio